Eli Lilly 2008 Annual Report Download - page 87

Download and view the complete annual report

Please find page 87 of the 2008 Eli Lilly annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 132

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132

PROXY STATEMENT
8585
Directors’ Outstanding Stock Options
Name Grant Date Expiration Date Exercise Price
Outstanding Stock Options
(Exercisable)
Sir Winfried Bischoff 2/20/2001
2/19/2002
2/18/2003
2/17/2004
2/18/2011
2/17/2012
2/18/2013
2/17/2014
$73.98
$75.92
$57.85
$73.11
2,800
2,800
2,800
2,800
Mr. Cook ——— 0
Mr. Eskew ——— 0
Dr. Feldstein 2/19/2002
2/18/2003
2/17/2004
2/17/2012
2/18/2013
2/17/2014
$75.92
$57.85
$73.11
2,800
2,800
2,800
Mr. Fyrwald ——— 0
Dr. Gilman 4/20/2000
2/20/2001
2/19/2002
2/18/2003
2/17/2004
4/19/2010
2/18/2011
2/17/2012
2/18/2013
2/17/2014
$75.94
$73.98
$75.92
$57.85
$73.11
2,800
2,800
2,800
2,800
2,800
Ms. Horn 4/20/2000
2/20/2001
2/19/2002
2/18/2003
2/17/2004
4/19/2010
2/18/2011
2/17/2012
2/18/2013
2/17/2014
$75.94
$73.98
$75.92
$57.85
$73.11
2,800
2,800
2,800
2,800
2,800
Ms. Marram 2/18/2003
2/17/2004
2/18/2013
2/17/2014
$57.85
$73.11
2,800
2,800
Mr. Oberhelman——— 0
Dr. Prendergast 4/20/2000
2/20/2001
2/19/2002
2/18/2003
2/17/2004
4/19/2010
2/18/2011
2/17/2012
2/18/2013
2/17/2014
$75.94
$73.98
$75.92
$57.85
$73.11
2,800
2,800
2,800
2,800
2,800
Ms. Seifert 4/20/2000
2/20/2001
2/19/2002
2/18/2003
2/17/2004
4/19/2010
2/18/2011
2/17/2012
2/18/2013
2/17/2014
$75.94
$73.98
$75.92
$57.85
$73.11
2,800
2,800
2,800
2,800
2,800
Directors and Corporate Governance Committee Matters
Overview
The directors and corporate governance committee recommends candidates for membership on the board
and board committees. The committee also oversees matters of corporate governance, director indepen-
dence, director compensation, and board performance. The committee’s charter is available online at
http://investor.lilly.com/governance.cfm or in paper form upon request to the company’s corporate secretary.
All committee members are independent as defi ned in the New York Stock Exchange listing requirements.
Director Nomination Process
The board seeks independent directors who represent a mix of backgrounds and experiences that will enhance
the quality of the board’s deliberations and decisions. Candidates shall have substantial experience with one or
more publicly traded national or multinational companies or shall have achieved a high level of distinction in their
chosen fi elds.
Board membership should refl ect diversity in its broadest sense, including persons diverse in geography, gen-
der, and ethnicity. The board is particularly interested in maintaining a mix that includes the following backgrounds:
• active or retired chief executive offi cers and senior executives, particularly those with experience in operations,
fi nance or banking, and marketing or sales
• international business
• medicine and science
• government and public policy
• health care environment and policy.